Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nobleoak LifeASX:NOL -1.59%47 3-Year EPS without NRI Growth Rate is 17.60% as of Jun. 2026, which is 74% below its 10-year median of 66.50. GuruFocus rates ASX:NOL with a GF Score™ of 47/100 and a GF Value™ of A$1.75 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 400 Insurance companies, Nobleoak Life ranks better than 52% on this metric.
During the past 12 months, Nobleoak Life's average EPS without NRI Growth Rate was -26.00% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 17.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 5 years, the highest 3-Year average EPS without NRI Growth Rate of Nobleoak Life was 115.40% per year. The lowest was 17.60% per year. And the median was 66.50% per year.
Nobleoak Life (ASX:NOL) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Nobleoak Life 3-Year EPS without NRI Growth Rate Related Terms
ASX:NOL vs MET, AFL, PRU: 3-Year EPS without NRI Growth Rate Comparison
For the Insurance - Life subindustry, Nobleoak Life's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nobleoak Life 3-Year EPS without NRI Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Nobleoak Life's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Nobleoak Life's 3-Year EPS without NRI Growth Rate falls into.
Nobleoak Life 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 17.60% mean?
Nobleoak Life (ASX:NOL) has a 3-Year EPS without NRI Growth Rate of 17.60% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Nobleoak Life and its competitors. This is 74% below median its historical median of 66.50. Over the past decade, Nobleoak Life's 3-Year EPS without NRI Growth Rate has ranged from 17.60 to 115.40. According to the industry distribution chart, Nobleoak Life ranks #192 out of 400 companies in the Insurance industry, placing it in the top 48%.
Is Nobleoak Life's 3-Year EPS without NRI Growth Rate too high?
Nobleoak Life's current 3-Year EPS without NRI Growth Rate of 17.60% is 74% below median its 10-year median of 66.50. Over the past 10 years, this metric has ranged from a low of 17.60 to a high of 115.40. The Insurance industry median 3-Year EPS without NRI Growth Rate is 16.25. Nobleoak Life's value of 17.60% is 8.3% above this industry median. Based on the distribution chart, Nobleoak Life ranks #192 out of 400 companies in the Insurance industry, which is above the industry midpoint. Overall, Nobleoak Life has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nobleoak Life's 3-Year EPS without NRI Growth Rate compare to MET and AFL?
According to the Insurance industry distribution chart, Nobleoak Life ranks #192 out of 400 companies for 3-Year EPS without NRI Growth Rate. This puts Nobleoak Life in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 16.25. Nobleoak Life's value of 17.60% is 8.3% above this benchmark. Historically, Nobleoak Life's own 3-Year EPS without NRI Growth Rate has ranged from 17.60 to 115.40 over the past decade. While the company's 10-year median is 66.50 vs. the industry median of 16.25, Nobleoak Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for an Insurance company?
The median 3-Year EPS without NRI Growth Rate among Insurance companies is 16.25, based on 400 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nobleoak Life's current 3-Year EPS without NRI Growth Rate of 17.60% is 8.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Nobleoak Life and its competitors. For the Insurance industry, the median 3-Year EPS without NRI Growth Rate is 16.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nobleoak Life's current 3-Year EPS without NRI Growth Rate is 17.60%, which is 74% below median its own 10-year median of 66.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nobleoak Life stock overvalued right now?
Based on GuruFocus' analysis, Nobleoak Life (ASX:NOL) is currently considered Modestly Undervalued. The stock's GF Value™ is A$1.75, compared to a current price of A$1.24 — trading 29.1% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 17.60%, which is 74% below median its 10-year median of 66.50 and 8.3% above the Insurance industry median of 16.25. Nobleoak Life's overall GF Score™ is 47/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Nobleoak Life (ASX:NOL), the current 3-Year EPS without NRI Growth Rate is 17.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nobleoak Life (ASX:NOL) Overvalued in 2026?
Based on GuruFocus' analysis, Nobleoak Life stock appears to be undervalued.
The current stock price of A$1.24 is trading 29.1% below its estimated GF Value™ of A$1.75.
GuruFocus considers Nobleoak Life to be Modestly Undervalued.
Key valuation signals for ASX:NOL:
3-Year EPS without NRI Growth Rate: 17.60% (74% below median its 10-year median of 66.50)
GF Value™: A$1.75 vs. price of A$1.24 (29.1% below fair value)
Industry Position: 8.3% above the Insurance median (#192 of 400)
No single metric tells the full story. See the ASX:NOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and Strategic Partner (Advised) channels. The company's segments include Direct Business, Strategic Partnerships, and Genus. It generates maximum revenue from the Direct segment.
47GF Score
Get the complete analysis for ASX:NOL
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:NOL has been successfully added to your 
